Abdullah M Alamri

7PUBLICATIONS
13CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsGenetically modified horticulture plants
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 27, 2026
Molecular Characterization of Ovarian Endometriosis in Saudi Arabian Women: Insights into Inflammatory, Autophagic, and Epigenetic Dysregulation.

|Jan 28, 2026
Correction: Almutairi et al. The Expression Patterns of Human Cancer-Testis Genes Are Induced through Epigenetic Drugs in Colon Cancer Cells. <i>Pharmaceuticals</i> 2022, <i>15</i>, 1319.

Mikhlid H Almutairi, Turki M Alrubie, Bader O Almutairi

|Aug 29, 2024
Differential expression and regulation of ADAD1, DMRTC2, PRSS54, SYCE1, SYCP1, TEX101, TEX48, and TMPRSS12 gene profiles in colon cancer tissues and their in vitro response to epigenetic drugs.

Mikhlid H Almutairi, Turki M Alrubie, Alaa T Alshareeda

|Jan 26, 2024
Rapamycin as a Potential Alternative Drug for Squamous Cell Gingiva Carcinoma (Ca9-22): A Focus on Cell Cycle, Apoptosis and Autophagy Genetic Profile.

Sofia Papadakos, Hawraa Issa, Abdulaziz Alamri

|Nov 24, 2023
Involvement of Autophagy and Oxidative Stress-Mediated DNA Hypomethylation in Transgenerational Nephrotoxicity Induced in Rats by the Mycotoxin Fumonisin B1.

Nouf Aldawood, Sarah Almustafa, Saleh Alwasel

|Jun 10, 2023
The Curcumin Analog PAC Is a Potential Solution for the Treatment of Triple-Negative Breast Cancer by Modulating the Gene Expression of DNA Repair Pathways.

Esraa Almalki, Abdullah Al-Amri, Reem Alrashed

Pageof 2

Frequent Collaborators

3 joint publications

Abdelhabib Semlali

3 joint publications

Mikhlid H Almutairi

2 joint publications

Abdel Halim Harrath

2 joint publications

Bader O Almutairi